The Effect Of Fluvastatin XL Treatment On The Lipid Profile In Patients With Metabolic Syndrome.

Trial Profile

The Effect Of Fluvastatin XL Treatment On The Lipid Profile In Patients With Metabolic Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 May 2011

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 14 Aug 2009 Actual patient number (614) added as reported by ClinicalTrials.gov.
    • 14 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top